In primary mediastinal large B-cell lymphoma, central nervous system (CNS) relapse is an uncommon event with a dismal prognosis. We report about the successful management of CNS relapse with chemoimmunotherapy according to MATRix (methotrexate, cytarabine, thiotepa, and rituximab) protocol followed by autologous stem cell transplant.
Marangon M., Casadei B., Broccoli A., Argnani L., Cavo M., Zinzani P.L. (2020). Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case report. CLINICAL CASE REPORTS, 8(6), 933-937 [10.1002/ccr3.2706].
Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case report
Marangon M.;Casadei B.;Broccoli A.;Argnani L.;Cavo M.;Zinzani P. L.
2020
Abstract
In primary mediastinal large B-cell lymphoma, central nervous system (CNS) relapse is an uncommon event with a dismal prognosis. We report about the successful management of CNS relapse with chemoimmunotherapy according to MATRix (methotrexate, cytarabine, thiotepa, and rituximab) protocol followed by autologous stem cell transplant.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
CCR3-8-933.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
181.07 kB
Formato
Adobe PDF
|
181.07 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
